Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Sitravatinib (MGCD516) and Nivolumab in Oral Cavity Cancer Window Opportunity Study (SNOW)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03575598
Recruitment Status : Completed
First Posted : July 2, 2018
Last Update Posted : April 1, 2021
Sponsor:
Collaborator:
Mirati Therapeutics Inc.
Information provided by (Responsible Party):
University Health Network, Toronto

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : February 18, 2020
Actual Study Completion Date : February 18, 2020